Illumina Corp - ILMN Net earnings per share for the last four quarters

Illumina Corp (ILMN) - corporate logo

Illumina, Inc. (ILMN) is the undisputed leader in molecular biology, investing in AI and ultra-fast DNA sequencing. The business relies on government grants and clinical applications, making it crisis-resistant. The current growth trend of EPS YoY TTM reflects the market consensus, where 31.60 determines this parameter level. High physician confidence and a cleansed corporate image following structural reforms strengthen the brand's position.

ILMN Illumina: Net earnings per share (EPS TTM) in the range 02/11/2024 - 11/18/2026

ILMN (Illumina, Inc.): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental valuation:ILMN - Illumina Inc
Flagship merchandise of Illumina Platform

Investors must distinguish between real profit growth and the effect of capital revaluation via WACC. Analyzing the current EPS YoY TTM growth rate reveals the net income dynamics over a rolling year relative to the previous period. This metric identifies organic business development, separating it from accounting adjustments. For Illumina, Inc. (ILMN), this is critical during restructuring and the rollout of new sequencers amid a dependence on government budgets.

Competitor analysis

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|EXAS - Net earnings per share for the last four quarters|Earnings per share for the last twelve months revvity.com|Earnings per share for the last twelve months BIO|Net earnings per share (EPS TTM) NNNN|SHC - Net earnings per one share for the last twelve months|Quidel Corporation - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) OPKO Health Corp. OPK|CDNA - Earnings per share for the last twelve months|Earnings per share for the trailing year MRVI (Maravai LifeSciences)|FLGT: Net earnings per share (EPS TTM)|Earnings per share for the last 12 months LAB|Earnings per share for the last twelve months Cytek Biosciences Inc|Net earnings per share (EPS TTM) OraSure Corp|Net earnings per share for the last 12 months XGN (Exagen Inc)|Net earnings per share (EPS TTM) mdxhealth.com (MDXH)|Net earnings per share (EPS TTM) LUCD (Lucid Diagnostics Inc)|PRE - Net earnings per share for the last 12 months|IMDX: Net earnings per share for the last 12 months|Earnings per share for the trailing year TRIB (trinitybiotech.com)|PRPH (ProPhase Labs, Inc.) - Net earnings per share for the last 12 months|Net earnings per share for the last 12 months Ainos|Earnings per share for the last twelve months Co-Diagnostics Inc|HSCS (Heart Test Laboratories Inc.) - Earnings per share for the last four quarters|Net earnings per share (EPS TTM) BMRA|Cardio Diagnostics Holdings Inc. (CDIO) - Net earnings per share for the trailing year|Earnings per share for the last twelve months Onconetix ONCO|viraxbiolabs.com - Earnings per share for the last twelve months|BJDX - Earnings per share for the last twelve months|Earnings per share for the trailing year AWH (Aspira Women's Health Inc.)|AXDX: Net earnings per share (EPS TTM)|CNTG - Net earnings per share for the last four quarters|ENZ (enzo.com) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months FRES|Earnings per share for the last twelve months Genetic Technologies (GENE)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)